Ivermectin: Can it be a potential therapy for COVID-19 prophylaxis? | Expert Opinion on the portal Medznat.ru, the latest materials. :- Medznat

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a rush to repurpose existing drugs for managing the infected patients.

This study aimed to evaluate the outcome of the second bDMARD (non-TNFi i.e rituximab, abatacept or tocilizumab, used individually) and TNFi) fol...

Medznat, an initiative of Dr. Reddy's Laboratories Ltd., is a resource for practicing doctors to enable their continuous learning. It provides unbiased and relevant medical information, apart from several other useful resources to aid their daily practice.

Medznat presents current medical information from the world's leading sources - the largest databases PubMed and DOAJ. Translation of articles made by ABBYY-LS.

The scientific editors of the Medznat website make sure that our publications are accurate, simple and useful to the readers. We are always glad for your questions or suggestions!

Categories

Attachment

Comments (0)

Recommendations

Next

Change Password!

Reset Password!

Reset Password!

Knowledge to Practice

Help Support

Attachment

Comments (0)

Recommendations

Related Tags

Next

Are you 21+ or a valid medical marijuana patient?